인쇄하기
취소

Bayer Healthcare completed taking over OTC drugs of MSD Korea

Published: 2015-06-05 13:45:56
Updated: 2015-06-05 13:45:56

The OTC drug department of Bayer Healthcare announced on the 3rd that it has completed taking over OTC drugs of MSD Korea, the Korean branch of Merk & Co., Inc. (hereinafter Merck).

The merger was conducted as the headquarters of Bayer took over the global OTC drug business of Merck on October 2014.

Products included in the merger are Clarityne(allergic rhinitis treatment), Drixine Nasal Spra...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.